Document is current
Any future updates will be listed below
-
Authors
Sediqi, Amena
Al-Khalili, Roya
Dover, Saunya
Peeters, Corien
Khalif, Adam
Sutton, V. Reid
Rauch, Frank
Lee, Brendan
Storch, Eric A.
Robinson, Marie-Eve
-
Funding
Funding for this research was provided by:
Osteogenesis Imperfecta Foundation
- License Information
-
More Information
Article History
Accepted: 23 July 2025
First Online: 14 August 2025
Declarations
:
: Saunya Dover reports full-time employment at Canada’s Drug Agency – Agence des Médicaments du Canada outside the submitted work. Frank Rauch reports study grants to institution from Mesentech, Ultragenyx, and Kirin. Brendan Lee reports consultancy fees from Biomarin and study grants to institution from Sanofi. Eric Storch reports receiving research funding to his institution from the Ream Foundation, International OCD Foundation, and NIH. He was a consultant for Brainsway and Biohaven Pharmaceuticals in the past 12 months. He owns stock less than $5000 in NView (for distribution of the Y-BOCS and CY-BOCS). He receives book royalties from Elsevier, Wiley, Oxford, American Psychological Association, Guildford, Springer, Routledge, and Jessica Kingsley. Marie-Eve Robinson reports study grants to institution from Ascendis Biopharma, Ipsen Biopharmaceuticals, and QED therapeutics; consultancy fees to institution from Ultragenyx and Ipsen Biopharmaceuticals.
